Comments for Observations about Generex (GNBT), Keryx (KERX), Sunesis (SNSS) and Cel-Sci (CVM) at http://www.biomedreports.com , comment 1 to 6 out of 6 comments http://www.biomedreports.com Thu, 24 May 2012 20:42:54 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/2010010623523/observations-about-generex-gnbt-keryx-kerx-sunesis-snss-and-cel-sci-cvm.html#comment-1789 I am long CVM but failed to understand Peter's take on CVM. Is 15K consider a large buy for Penny stock..Doesn't make sense. but I do agree that announcements are coming sooner then we think. - SYED AHMED1 Fri, 08 Jan 2010 10:14:04 +0100 http://www.biomedreports.com/2010010623523/observations-about-generex-gnbt-keryx-kerx-sunesis-snss-and-cel-sci-cvm.html#comment-1782 huge amount of shareS!!!!!! next to nothing bought nominal at best would not use word large!!!! - joseph Thu, 07 Jan 2010 08:37:34 +0100 http://www.biomedreports.com/2010010623523/observations-about-generex-gnbt-keryx-kerx-sunesis-snss-and-cel-sci-cvm.html#comment-1780 I think OCLS is a good buy right now...good 2010 milestones (lots of them too). - pheet Thu, 07 Jan 2010 05:52:24 +0100 http://www.biomedreports.com/2010010623523/observations-about-generex-gnbt-keryx-kerx-sunesis-snss-and-cel-sci-cvm.html#comment-1771 CVM alerted at .70 and it ran to $2pps before Adam F. totally bashed CVM. We will be back very soon as well :) - TooNiceStocks.com Wed, 06 Jan 2010 07:20:19 +0100 http://www.biomedreports.com/2010010623523/observations-about-generex-gnbt-keryx-kerx-sunesis-snss-and-cel-sci-cvm.html#comment-1766 I am a big fan of Cel-Sci but it is incorrect to imply that the listed insiders are exercising warrants because of any announcement that may or may not be forthcoming. Warrants (these included) are exercisable at a stated price independent of the share price for the term of the warrants. - Roy Malis Wed, 06 Jan 2010 05:32:22 +0100 http://www.biomedreports.com/2010010623523/observations-about-generex-gnbt-keryx-kerx-sunesis-snss-and-cel-sci-cvm.html#comment-1761 The December 3, 2009 Generex news release states: "WORCESTER, Mass., Dec. 3, 2009 (GLOBE NEWSWIRE) -- Published in the journal Diabetes, Obesity and Metabolism, an independent review of clinical trials of Generex Oral-lyn(TM) shows that the oral insulin spray has a faster onset of action and shorter duration of action than insulin delivered subcutaneously." This answers the second part of the GNBT question above. Hope this helps. Regards - Barry Feigen Wed, 06 Jan 2010 00:03:42 +0100